Engineered fusion reverse transcriptases with specific mutations enhance transcription efficiency by resolving RNA secondary structure interference.
A single base editor converts mutated cytosine to thymine in the HBA2 gene sequence without inducing double-strand breaks.
Targeted integration into albumin gene loci eliminates malignancy risks from random insertion while sustaining durable expression.
A hybrid polymerase conjugate enhances nucleic acid amplification efficiency through linked binding domains.
An alternative RVD matrix maps repeat variable diresidues to nucleic acid bases, streamlining TALE-nuclease assembly and reducing off-target events.
Segmented TALE monomers enable precise genome targeting, resolving the trade-off between manipulation efficiency and binding specificity.
A bidirectional constitutive promoter drives simultaneous expression of multiple transgenes in plant cells using a single regulatory element.
Mutant thermophilic DNA polymerases with neutral amino acid residues at position 379 enable efficient nucleic acid amplification.
Modified TALENs delete endogenous T cell receptors in regulatory T cells to prevent co-expression and ensure high specificity.
A recombinant fusion protein recruits linear DNA inserts to genomic cleavage sites.
Genetically engineered yeast cells express fusion proteins to detect therapeutic molecules via chemical inducers of dimerization.
Modular fusion proteins detect metabolites to overcome limited biosensor availability.
Reducing endogenous target genes in immune cells using CRISPR-Cas or siRNA to overcome exhaustion in solid malignancies.
Cas12a nuclease proteins disrupt the 4qA polyadenylation signal sequence to reduce DUX4 expression, addressing permanent genetic mutation repair.
TALENs cleave latent HSV-1 genomes via AAV delivery, eliminating persistent viral loads that conventional antivirals cannot address.
De novo designed small helical polypeptides achieve programmable DNA targeting while bypassing the size and delivery limits of CRISPR-Cas systems.
Phase-shifted droplets concentrate fluorescent proteins to overcome tissue autofluorescence and light scattering during imaging.
A modular molecular complex tethers synthetic transcription factors to tandem DNA binding motifs via a molecular clamp.
Zinc finger fusion proteins repress alpha-synuclein expression via targeted SNCA gene binding.